SCHEMBL4400408

SCHEMBL4400408

CN(C)CCCOC(=O)Nc1cccc(Cn2nc(-c3cccc(N)c3)ccc2=O)c1

nearest known ligand 0.78

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ MET P08581 20/20 0.78

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4134251 0.90 MET (0.89) MET
SCHEMBL4135688 0.90 MET (0.78) MET
SCHEMBL2672814 0.89 MET (0.75) MET
SCHEMBL2672565 0.88 MET (0.78) MET
SCHEMBL2673679 0.88 MET (0.85) MET
SCHEMBL4135272 0.87 MET (0.84) MET
SCHEMBL2672383 0.87 MET (1.00) MET
SCHEMBL2672352 0.87 MET (0.81) MET
SCHEMBL4125758 0.87 MET (1.00) MET
SCHEMBL13247285 0.87 MET (0.75) MET

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8173653-B2 Pyridiazinone derivatives for the treatment of tumours MERCK PATENT GESELLSCHAFT MIT BESCHRAENKTER HAFTUNG (DE) 2012-05-08 — — US disclosed
EP-1960370-B1 PYRIDIAZINONE DERIVATIVES FOR TUMOUR TREATMENT MERCK PATENT GMBH (DE) 2011-10-05 — — EP disclosed
WO-2007065518-A1 PYRIDIAZINONE DERIVATIVES FOR TUMOUR TREATMENT MERCK PATENT GMBH (DE) 2007-06-14 — — WO disclosed
Send feedback